Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma
Clinical trial NCT01526135 · COMPLETED
Trial details
- NCT number
- NCT01526135
- Sponsor
- UNICANCER
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-16
- Primary completion
- 2018-03-01
- Enrollment
- 493
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.